U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H23N7O
Molecular Weight 401.4643
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RISDIPLAM

SMILES

CC1=CN2N=C(C=C(C)C2=N1)C3=CC(=O)N4C=C(C=CC4=N3)N5CCNC6(CC6)C5

InChI

InChIKey=ASKZRYGFUPSJPN-UHFFFAOYSA-N
InChI=1S/C22H23N7O/c1-14-9-18(26-29-11-15(2)24-21(14)29)17-10-20(30)28-12-16(3-4-19(28)25-17)27-8-7-23-22(13-27)5-6-22/h3-4,9-12,23H,5-8,13H2,1-2H3

HIDE SMILES / InChI

Approval Year

2020
842
Name Type Language
RISDIPLAM
INN   USAN  
Official Name English
RO-7034067
Code English
RG-7916
Code English
RO7034067
Code English
RISDIPLAM [USAN]
Common Name English
RG7916
Code English
EVRYSDI
Brand Name English
RISDIPLAM [JAN]
Common Name English
Risdiplam [WHO-DD]
Common Name English
RISDIPLAM [ORANGE BOOK]
Common Name English
RISDIPLAM [MI]
Common Name English
risdiplam [INN]
Common Name English
(7-(4,7-DIAZASPIRO(2.5)OCTAN-7-YL)-2-(2,8-DIMETHYLIMIDAZO(1,2-B)PYRIDAZIN-6-YL)PYRIDO(1,2-A)PYRIMIDIN-4-ONE
Systematic Name English
4H-PYRIDO(1,2-A)PYRIMIDIN-4-ONE, 7-(4,7-DIAZASPIRO(2.5)OCT-7-YL)-2-(2,8-DIMETHYLIMIDAZO(1,2-B)PYRIDAZIN-6-YL)-
Systematic Name English
Classification Tree Code System Code
EU-Orphan Drug EU/3/19/2145
Created by admin on Sun Dec 18 21:23:57 UTC 2022 , Edited by admin on Sun Dec 18 21:23:57 UTC 2022
FDA ORPHAN DRUG 548116
Created by admin on Sun Dec 18 21:23:57 UTC 2022 , Edited by admin on Sun Dec 18 21:23:57 UTC 2022
Code System Code Type Description
INN
10614
Created by admin on Sun Dec 18 21:23:57 UTC 2022 , Edited by admin on Sun Dec 18 21:23:57 UTC 2022
PRIMARY
CAS
1825352-65-5
Created by admin on Sun Dec 18 21:23:57 UTC 2022 , Edited by admin on Sun Dec 18 21:23:57 UTC 2022
PRIMARY
EVMPD
SUB193759
Created by admin on Sun Dec 18 21:23:57 UTC 2022 , Edited by admin on Sun Dec 18 21:23:57 UTC 2022
PRIMARY
NCI_THESAURUS
C167001
Created by admin on Sun Dec 18 21:23:57 UTC 2022 , Edited by admin on Sun Dec 18 21:23:57 UTC 2022
PRIMARY
DAILYMED
76RS4S2ET1
Created by admin on Sun Dec 18 21:23:57 UTC 2022 , Edited by admin on Sun Dec 18 21:23:57 UTC 2022
PRIMARY
RXCUI
2390935
Created by admin on Sun Dec 18 21:23:57 UTC 2022 , Edited by admin on Sun Dec 18 21:23:57 UTC 2022
PRIMARY
DRUG BANK
DB15305
Created by admin on Sun Dec 18 21:23:57 UTC 2022 , Edited by admin on Sun Dec 18 21:23:57 UTC 2022
PRIMARY
USAN
FG-179
Created by admin on Sun Dec 18 21:23:57 UTC 2022 , Edited by admin on Sun Dec 18 21:23:57 UTC 2022
PRIMARY
FDA UNII
76RS4S2ET1
Created by admin on Sun Dec 18 21:23:57 UTC 2022 , Edited by admin on Sun Dec 18 21:23:57 UTC 2022
PRIMARY
WIKIPEDIA
Risdiplam
Created by admin on Sun Dec 18 21:23:57 UTC 2022 , Edited by admin on Sun Dec 18 21:23:57 UTC 2022
PRIMARY
PUBCHEM
118513932
Created by admin on Sun Dec 18 21:23:57 UTC 2022 , Edited by admin on Sun Dec 18 21:23:57 UTC 2022
PRIMARY
MERCK INDEX
M12240
Created by admin on Sun Dec 18 21:23:57 UTC 2022 , Edited by admin on Sun Dec 18 21:23:57 UTC 2022
PRIMARY
ACTIVE MOIETY
Structure of RISDIPLAM
METABOLITE INACTIVE (PARENT)
Structure of RISDIPLAM METABOLITE M1
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966